Novel Approaches to Studying SLC13A5 Disease
The role of the sodium citrate transporter (NaCT) SLC13A5 is multifaceted and context-dependent.While aberrant dysfunction leads to neonatal sensationnel kiyari epilepsy, its therapeutic inhibition protects against metabolic disease.Notably, insights regarding the cellular and molecular mechanisms underlying these phenomena are limited due to the i